Abstract
P wave dispersion (PWD) is a sign for the prediction of atrial fibrillation (AF). The aim of this study was to assess P wave dispersion and its relation with clinical and echocardiographic parameters in patients with rheumatoid arthritis (RA). Thirty RA patients (mean age 49 ± 10 years) and 27 healthy controls (mean age 47 ± 8 years) were included in the study. We performed electrocardiography and Doppler echocardiography on patients and controls. Maximum and minimum P wave duration were obtained from electrocardiographic measurements. PWD defined as the difference between maximum and minimum P wave duration was also calculated. Maximum P wave duration and PWD was higher in RA patients than controls (P = 0.031 and P = 0.001, respectively). However, there was no significant difference in minimum P wave duration between the two groups (P = 0.152). There was significant correlation between PWD and disease duration (r = 0.375, P = 0.009) and isovolumetric relaxation time (r = 0.390, P = 0.006). P wave duration and PWD was found to be higher in RA patients than healthy control subjects. PWD is closely associated with disease duration and left ventricular (LV) diastolic dysfunction.
Similar content being viewed by others
References
Wallberg-Jonsson S, Öhman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 24:445–451
Wislowska M, Sypula S, Kowalik I (1998) Echocardiographic findings, 24-hour electrocardiographic holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler–Rose titre and duration of disease. Clin Rheumatol 17:369–377
Koopman WJ, Moreland LW (2005) Arthritis and allied conditions. A textbook of rheumatology, 15th edn. Lippincott Williams & Wilkins, Philadelphia
Goldeli O, Dursun E, Komsuoglu B (1998) Dispersion of ventricular repolarisation: a new marker of ventricular arrhythmic in patients with rheumatoid arthritis. J Rheumatol 25:447–450
Pırıldar T, Sekuri C, Utuk O, Tezcan UK (2003) QT dispersion in rheumatoid arthritis patients with and without Sjögren’s syndrome. Clin Rheumatol 22:225–228
Dilaveris PE, Gialafos EJ, Sideris S, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738
Dilaveris PE, Gialofos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, Gialafos JE (2000) Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23:352–358
Dilaveris PE, Gialafos JE (2001) P wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159–165
Arnett FC, Edwothy SM, Bloch DA, Meshane DJ, Fries JF, Cooper NS (1988) The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Steinbrocker O, Treger H, Cornelius H (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
Van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458
Mutru O, Laakso M, İsomaki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77
Mody GM, Stevens JE, Meyers OL (1987) The heart in rheumatoid arthritis: a clinical and echocardiographic study. Q J Med 65:921–928
Cindas A, Gokce-Kutsal Y, Tokgozoklu L, Karanfil A (2002) QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol 31:22–26
Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJF (2003) Rheumatoid arthritis and macrovascular disease. Rheumatology 42:292–297
Yildirir A, Aksoyek S, Calguneri M, Aytemir K, Kabakci G, Ovunç K, Nazlı F, Ozmen A, Oto A, Kes S (2000) QT dispersion as a predictor of arrhythmic events in patients with ankylosing spondylitis. Rheumatology 39:875–879
Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ (1990) Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26:497–502
Leier CV, Meacham JA, Schall SF (1978) Prolonged atrial conduction: a major predisposing factor to atrial flutter. Circulation 57:213–216
Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunç K, Oto A, Ozmen F, Kes S (2000) P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation . Pacing Clin Electrophysiol 23:1109–1112
Yilmaz R, Demirbag R (2005) P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. J Electrocardiol 38(3):279–284
Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, Uyan C (2005) The relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J 32:163–167
Yilmaz R, Kasap H, Baykan M, Durmus I, Kaplan S, Celik S, Erdol C (2005) Assessment of left ventricular function by Doppler tissue imaging in patients with atrial fibrillation following acute myocardial infarction. Int J Cardiol 102:79–85
Bonfiglio T, Atwater EC (1969) Heart disease in patients with seropositive rheumatoid arthritis. Arch Intern Med 124:714–719
Reimer KA, Rodgers RF, Oyasu R (1976) Rheumatoid arthritis with rheumatoid heart disease and granulomatous aortitis. JAMA 235:2510–2512
Morris PB (1986) Rheumatoid arthritis and coronary arteritis. Am J Cardiol 57:689–690
Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM (1993) Restrictive cardiomyopathy caused by chloroquine. Br Heart J 69:451–452
Ratliff NB, Estes ML, Myles JL, Shirey EK, McMahon JT (1987) Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 316:191–193
Qasim FJ, Thiru S, Gillespie K (1997) Gold and D-penicillamine induce vasculitis and up-regulate m RBA for IL-4 in the Brown Norway rat: support for a role of Th2 cell activity. Clin Exp Immunol 108:438–445
Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients. Arch Intern Med 160:777–784
Nashel D (1986) Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 80:925–929
Landewe R, van den Borne B, Breedveld F, et al. (2000) Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 355:1616–1617
Haagsma C, Blom H, van Riel PL, et al. (1999) Influence of sulfasalazine, methotrexate and combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79–84
Schiff MH, Strand V, Oed C, Loew-Frriedrich I (2000) Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis. Drugs Today Barc 36:383–394
Tukek T, Akkaya V, Demirel S, Sozen AB, Kudat H, Atılgan D, Ozcan M, Guven O, Korkut F (2000) Effect of valsalva maneuver on surface electrocardiographic P wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 85:896–899
Evrengul H, Dursunoglu D, Cobankara N, Polat B, Seleci D, Kabukcu S, Kaftan A (2004) Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int 24:198–202
Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ (2004) Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol 22:63–70
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guler, H., Seyfeli, E., Sahin, G. et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 27, 813–818 (2007). https://doi.org/10.1007/s00296-007-0307-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-007-0307-8